Literature DB >> 1740516

Plasma viscosity in inflammatory bowel disease.

A J Lobo1, S C Jones, L D Juby, A T Axon.   

Abstract

AIMS: To assess the relation of plasma viscosity to disease activity in patients with inflammatory bowel disease.
METHODS: Crohn's disease (n = 60) and ulcerative colitis (n = 71) were diagnosed on the basis of typical histological or radiological features. Active Crohn's disease was defined as a Crohn's disease activity index of 150 or over. Active ulcerative colitis was defined as a liquid stool passed three times a day or more with blood. Blood samples were assessed for haemoglobin concentration, total white cell count, platelets, plasma viscosity, erythrocyte sedimentation rate, serum albumin, and C-reactive protein.
RESULTS: Plasma viscosity was higher in those with active Crohn's disease compared with those with inactive Crohn's disease or active ulcerative colitis. Plasma viscosity correlated significantly with erythrocyte sedimentation rate, C-reactive protein, and platelet count in patients with Crohn's disease. In ulcerative colitis plasma viscosity correlated only with serum C-reactive protein. Plasma viscosity showed a low sensitivity for detecting active Crohn's disease, with 48% of those with active disease having a plasma viscosity within the laboratory reference range.
CONCLUSIONS: Plasma viscosity is related to disease activity in Crohn's disease, but is insufficiently sensitive for it to replace erythrocyte sedimentation rate as a measure of the acute phase response in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740516      PMCID: PMC495816          DOI: 10.1136/jcp.45.1.54

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  Efficacy of tests used to monitor rheumatoid arthritis.

Authors:  B S Bull; J C Westengard; M Farr; P A Bacon; P J Meyer; J Stuart
Journal:  Lancet       Date:  1989-10-21       Impact factor: 79.321

3.  Automated measurement of plasma viscosity by capillary viscometer.

Authors:  B M Cooke; J Stuart
Journal:  J Clin Pathol       Date:  1988-11       Impact factor: 3.411

4.  NHS 1948-88: less ideology, more humanity.

Authors:  S Lock
Journal:  BMJ       Date:  1988-07-02

5.  A comparison of the erythrocyte sedimentation rate and plasma viscosity in detecting changes in plasma proteins.

Authors:  R M Hutchinson; R D Eastham
Journal:  J Clin Pathol       Date:  1977-04       Impact factor: 3.411

6.  Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.

Authors:  E A Fagan; R F Dyck; P N Maton; H J Hodgson; V S Chadwick; A Petrie; M B Pepys
Journal:  Eur J Clin Invest       Date:  1982-08       Impact factor: 4.686

Review 7.  Blood rheology in the newborn infant.

Authors:  O Linderkamp
Journal:  Baillieres Clin Haematol       Date:  1987-09

8.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

9.  Plasma viscosity--a new appraisal of its use as an index of disease activity in rheumatoid arthritis.

Authors:  M E Pickup; J S Dixon; C Hallett; H A Bird; V Wright
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

10.  Differing acute phase responses in Crohn's disease and ulcerative colitis.

Authors:  S H Saverymuttu; H J Hodgson; V S Chadwick; M B Pepys
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

View more
  3 in total

1.  Erythrocyte deformability and oxidative stress in inflammatory bowel disease.

Authors:  Tulay Akman; Mesut Akarsu; Hale Akpinar; Halil Resmi; Ebru Taylan; Ebru Sezer
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

2.  Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non-coeliac, non-IBD subjects (HERMES): a case-control study protocol.

Authors:  Péter Hegyi; Judit Bajor; Zsolt Szakács; Beáta Csiszár; Péter Kenyeres; Patrícia Sarlós; Bálint Erőss; Alizadeh Hussain; Ágnes Nagy; Balázs Kőszegi; Ibolya Veczák; Nelli Farkas; Emőke Bódis; Katalin Márta; Andrea Szentesi; Margit Tőkés-Füzesi; Tímea Berki; Áron Vincze; Kálmán Tóth
Journal:  BMJ Open       Date:  2019-03-23       Impact factor: 2.692

3.  Diet-Dependent and Diet-Independent Hemorheological Alterations in Celiac Disease: A Case-Control Study.

Authors:  Zsolt Szakács; Beáta Csiszár; Mátyás Nagy; Nelli Farkas; Péter Kenyeres; Adrienn Erős; Alizadeh Hussain; Katalin Márta; Andrea Szentesi; Margit Tőkés-Füzesi; Tímea Berki; Áron Vincze; Kálmán Tóth; Péter Hegyi; Judit Bajor
Journal:  Clin Transl Gastroenterol       Date:  2020-11       Impact factor: 4.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.